Clinical trial
Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02…
NCT00370006 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00370006 |
|---|---|
| Title | Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM |
| Official title | A Phase 1 Clinical Trial to Evaluate the Safety of, and Kinetics and Magnitude of the CMV-Specific Immune Response to, Challenge With a Live Attenuated Strain of CMV (Towne) in Healthy, CMV- Seronegative, Adult Subjects Who Previously Received a CMV Immunotherapeutic Trivalent pDNA Vaccine (VCL… |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | Vical Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cytomegalovirus Infection |
| Intervention type | Biological |
| Interventions | Towne CMV vaccine |
| Enrollment | 10 |
| Start date | Sep 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | Aug 30, 2006 |
| Last update posted | Jan 11, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: